Spain Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Report Overview

Table of Contents

1596.68

Select License Type

£1,596.68	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£3,193.35	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£4,790.03	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£1,596.68	Add to Wishlist
Change Currency	GBP EURO USD
	Order By Fax

Market	Healthcare and Medical
Report Type	Market Research
Country	Spain
Published	2 June 2009
Number of Pages	112
Report Delivery	Email
Delivery Lead Time	-
Publisher	Global Markets Direct
File Format	-

Spain Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Spain diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices market in Spain

Scope

- The report provides diabetes care devices information broken down into detailed categories and segments in Spain.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the diabetes care devices market in Spain.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

£1,596.68	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£3,193.35	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£4,790.03	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£1,596.68	Add to Wishlist
Change Currency	GBP EURO USD

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 10
2.1 What Is This Report About? 10
3 Definitions of Markets Covered in the Report 11
3.1 Diabetes Care Devices 11
3.2 Glucose Monitoring Devices 11
3.2.1 Blood Glucose Meters 11
3.2.2 Blood Glucose Strips 11
3.3 Insulin Delivery 11
3.3.1 Insulin Pens 11
3.3.2 Insulin Syringes 12
3.3.3 Insulin Pumps 12
3.3.4 Traditional Insulin Pump Accessories 12
4 Healthcare Sector Review 13
4.1 Healthcare Expenditure 13
4.2 Healthcare Infrastructure 14
4.3 Healthcare Policy 18
5 Regulation System 20
5.1 Medical Equipment Approval Process 20
5.1.1 Classification of medical devices 20
5.1.2 Conformity Assessment Process 29
5.2 Post Market Surveillance (PMS) 32
6 Pricing and Reimbursement 33
6.1 Pricing and Reimbursement Policies 33
7 Distribution Structure 34
8 Diabetes Care Devices In Spain 35
8.1 Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015 35
8.2 Diabetes Care Devices, Spain, Overall Revenue ($ mn), 2000-2015 36
8.3 Diabetes Care Devices, Spain, Category Volume (Units), 2000-2015 40
8.4 Diabetes Care Devices, Spain, Company Share (2007-2008) 43
9 Glucose Monitoring In Spain 44
9.1 Glucose Monitoring Overall Revenue (2000-2015) 44
9.1.1 Blood Glucose Meters Overall Revenue (2000-2015) 46
9.2 Glucose Monitoring Overall Volume (2000-2015) 48
9.2.1 Blood Glucose Meters Overall Volume (2000-2015) 50
9.3 Glucose Monitoring Average Price (2000-2015) 51
9.4 Glucose Monitoring Distribution Share (2007-2008) 52
9.5 Glucose Monitoring, Spain, Company Share (2007-2008) 53
10 Insulin Delivery In Spain 54
10.1 Insulin Delivery Overall Revenue (2000-2015) 54
10.1.1 Insulin Pens Overall Revenue (2000-2015) 56
10.2 Insulin Delivery Overall Volume (2000-2015) 58
10.2.1 Insulin Pens Overall Volume (2000-2015) 59
10.3 Insulin Delivery Average Price (2000-2015) 61
10.4 Insulin Delivery Distribution Share (2007-2008) 62
10.5 Insulin Delivery, Spain, Company Share (2007-2008) 63
11 Overview of Key Companies in Spain Diabetes Care Devices Market 64
11.1 F. Hoffmann-La Roche Ltd. 64
11.1.1 Company Overview 64
11.1.2 Value Chain Analysis 65
11.1.3 F. Hoffmann-La Roche Ltd Pipeline Products 67
11.2 Bayer HealthCare AG 68
11.2.1 Company Overview 68
11.2.2 Value Chain Analysis 69
11.2.3 Bayer HealthCare AG Pipeline Products 71
11.3 Abbott Laboratories 72
11.3.1 Company Overview 72
11.3.2 Value Chain Analysis 73
11.3.3 Abbott Laboratories Pipeline Products 75
11.4 Becton, Dickinson and Company 77
11.4.1 Company Overview 77
11.4.2 Value Chain Analysis 77
11.5 Novo Nordisk A/S 79
11.5.1 Company Overview 79
11.5.2 Novo Nordisk A/S Pipeline Products 79
11.6 Medtronic, Inc. 81
11.6.1 Company Overview 81
11.6.2 Value Chain Analysis 82
11.6.3 Medtronic, Inc. Pipeline Products 84
11.7 Eli Lilly and Company 92
11.7.1 Company Overview 92
11.7.2 Value Chain Analysis 92
11.7.3 Eli Lilly and Company Pipeline Products 95
11.8 LifeScan, Inc. 96
11.8.1 Company Overview 96
11.8.2 LifeScan, Inc. Pipeline Products 96
11.9 ARKRAY, Inc. 98
11.9.1 Company Overview 98
11.9.2 ARKRAY, Inc. Pipeline Products 98
11.10 Terumo Corporation 100
11.10.1 Company Overview 100
11.10.2 Value Chain Analysis 100
11.11 Animas Corporation 103
11.11.1 Company Overview 103
11.12 Sanofi-Aventis 103
11.12.1 Company Overview 103
11.13 Smiths Medical 104
11.13.1 Company Overview 104
11.13.2 Value Chain Analysis 105
12 Appendix 107
12.1 Global Markets Direct Research Methodology 107
12.2 Coverage 108
12.3 Secondary Research 108
12.4 Primary Research 109
12.5 Models 109
12.6 Forecasts 110
12.7 Expert Panel Validation 110
12.8 Currency Conversion 111
12.9 Contact Us 112
12.10 Disclaimer 112

1.1 List of Tables
Table 1: Number of Doctors by Specialty in Spain, 2003-2007 15
Table 2: Number of Hospital Wards by Specialty in Spain, 2003-2007 16
Table 3: Healthcare Institutions in Spain, 2007 17
Table 4: Hospital Beds by Type in Spain, 2007 17
Table 5: Number of Healthcare Personnel in Spain, 2007 18
Table 6: Number of Selected Medical Equipment in Spain, 2007 18
Table 7: Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015 35
Table 8: Diabetes Care Devices, Spain, Overall Revenue ($ mn), 2000-2015 36
Table 9: Diabetes Care Devices, Spain, Cross-Category Analysis, 2000-2015 37
Table 10: Diabetes Care Devices, Spain, Overall Revenue ($ mn), Historic, 2000-2008 38
Table 11: Diabetes Care Devices, Spain, Overall Revenue ($ mn), Forecast, 2008-2015 39
Table 12: Diabetes Care Devices, Spain, Category Volume (Units), 2000-2015 40
Table 13: Diabetes Care Devices, Spain, Category Volume (Units), Historic, 2000-2008 41
Table 14: Diabetes Care Devices, Spain, Category Volume (Units), Forecast, 2008-2015 42
Table 15: Diabetes Care Devices, Spain, Company Share by Revenue ($ mn), 2007-2008 43
Table 16: Glucose Monitoring, Spain, Revenue ($ mn) by Segment, Historic, 2000-2008 44
Table 17: Glucose Monitoring, Spain, Revenue ($ mn) by Segment, Forecast, 2008-2015 45
Table 18: Blood Glucose Meters, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 46
Table 19: Blood Glucose Meters, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 47
Table 20: Glucose Monitoring, Spain, Volume (Units) by Segment, Historic, 2000-2008 48
Table 21: Glucose Monitoring, Spain, Volume (Units) by Segment, Forecast, 2008-2015 49
Table 22: Blood Glucose Meters, Spain, Volume (Units) by Sub-Segment, Historic, 2000-2008 50
Table 23: Blood Glucose Meters, Spain, Volume (Units) by Sub-Segment, Forecast, 2008-2015 50
Table 24: Glucose Monitoring, Spain, Average Price ($), Historic, 2000-2008 51
Table 25: Glucose Monitoring, Spain, Average Price ($), Forecast, 2008-2015 51
Table 26: Glucose Monitoring, Spain, Distribution Share by Revenue ($mn), 2007-2008 52
Table 27: Glucose Monitoring, Spain, Company Share by Revenue ($ mn), 2007-2008 53
Table 28: Insulin Delivery, Spain, Revenue ($ mn) by Segment, Historic, 2000-2008 54
Table 29: Insulin Delivery, Spain, Revenue ($ mn) by Segment, Forecast, 2008-2015 55
Table 30: Insulin Pens, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 56
Table 31: Insulin Pens, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 57
Table 32: Insulin Delivery, Spain, Volume (Units) by Segment, Historic, 2000-2008 58
Table 33: Insulin Delivery, Spain, Volume (Units) by Segment, Forecast, 2008-2015 58
Table 34: Insulin Pens, Spain, Volume (Units) by Sub-Segment, Historic, 2000-2008 59
Table 35: Insulin Pens, Spain, Volume (Units) by Sub-Segment, Forecast, 2008-2015 60
Table 36: Insulin Delivery, Spain, Average Price ($), Historic, 2000-2008 61
Table 37: Insulin Delivery, Spain, Average Price ($), Forecast, 2008-2015 61
Table 38: Insulin Delivery, Spain, Distribution Share by Revenue ($mn), 2007-2008 62
Table 39: Insulin Delivery, Spain, Company Share by Revenue ($ mn), 2007-2008 63
Table 40: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type 67
Table 41: F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage 67
Table 42: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy Area 67
Table 43: Bayer HealthCare AG Pipeline Products by Equipment Type 71
Table 44: Bayer HealthCare AG Pipeline Products by Development Stage 71
Table 45: Bayer HealthCare AG Pipeline Products by Therapy Area 71
Table 46: Bayer HealthCare AG Pipeline Products by News Summary 71
Table 47: Abbott Laboratories Pipeline Products by Equipment Type 75
Table 48: Abbott Laboratories Pipeline Products by Development Stage 75
Table 49: Abbott Laboratories Pipeline Products by Therapy Area 75
Table 50: Abbott Laboratories Pipeline Products by Clinical Trials 76
Table 51: Abbott Laboratories Pipeline Products by News Summary 76
Table 52: Novo Nordisk A/S Pipeline Products by Equipment Type 79
Table 53: Novo Nordisk A/S Pipeline Products By Development Stage 79
Table 54: Novo Nordisk A/S Pipeline Products By Therapy Area 80
Table 55: Novo Nordisk A/S Pipeline Products By Clinical Trials 80
Table 56: Medtronic, Inc. Pipeline Products by Equipment Type 84
Table 57: Medtronic, Inc. Pipeline Products By Development Stage 86
Table 58: Medtronic, Inc. Pipeline Products By Therapy Area 88
Table 59: Medtronic, Inc. Pipeline Products By Clinical Trials 90
Table 60: Medtronic, Inc. Pipeline Products By News Summary 91
Table 61: Eli Lilly and Company Pipeline Products by Equipment Type 95
Table 62: Eli Lilly and Company Pipeline Products by Development Stage 95
Table 63: Eli Lilly and Company Pipeline Products by Therapy Area 95
Table 64: Eli Lilly and Company Pipeline Products by Clinical Trials 95
Table 65: Eli Lilly and Company Pipeline Products by News Summary 95
Table 66: LifeScan, Inc. Pipeline Products by Equipment Type 96
Table 67: LifeScan, Inc. Pipeline Products by Development Stage 96
Table 68: LifeScan, Inc. Pipeline Products by Therapy Area 96
Table 69: LifeScan, Inc. Pipeline Products by Clinical Trials 97
Table 70: LifeScan, Inc. Pipeline Products by News Summary 97
Table 71: ARKRAY, Inc. Pipeline Products by Equipment Type 98
Table 72: ARKRAY, Inc. Pipeline Products by Development Stage 98
Table 73: ARKRAY, Inc. Pipeline Products by Clinical Trials 98
Table 74: ARKRAY, Inc. Pipeline Products by News Summary 99
Table 75: USD to Local Currency, Average Exchange Rate 2008 111

1.2 List of Figures
Figure 1: Total Healthcare Expenditure in Spain, 2000 – 2006 14
Figure 2: Flowchart for Classification of Non-invasive Devices in Spain, 2007 21
Figure 3: Flowchart for Classification of Invasive Devices in Spain, 2007 22
Figure 4: Flowchart for Classification of Invasive Devices in Spain, 2007 23
Figure 5: Flowchart for Classification of Invasive Devices in Spain, 2007 24
Figure 6: Flowchart for Classification of Invasive Devices in Spain, 2007 25
Figure 7: Flowchart for Classification of Active Devices in Spain, 2007 26
Figure 8: Flowchart for Classification of Active Devices in Spain, 2007 27
Figure 9: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Spain, 2007 28
Figure 10: Conformity Assessment of Class-I Medical Devices in Spain, 2007 29
Figure 11: Conformity Assessment of Class-IIa Medical Devices in Spain, 2007 30
Figure 12: Conformity Assessment of Class-IIb Medical Devices in Spain, 2007 31
Figure 13: Conformity Assessment of Class-III Medical Devices in Spain, 2007 32
Figure 14: Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015 35
Figure 15: Diabetes Care Devices, Spain, Overall Revenue ($ mn), 2000-2015 36
Figure 16: Diabetes Care Devices, Spain, Cross-Category Analysis, 2000-2015 37
Figure 17: Diabetes Care Devices, Spain, Overall Revenue ($ mn), Historic, 2000-2008 38
Figure 18: Diabetes Care Devices, Spain, Overall Revenue ($ mn), Forecast, 2008-2015 39
Figure 19: Diabetes Care Devices, Spain, Category Volume (Units), 2000-2015 40
Figure 20: Diabetes Care Devices, Spain, Category Volume (Units), Historic, 2000-2008 41
Figure 21: Diabetes Care Devices, Spain, Category Volume (Units), Forecast, 2008-2015 42
Figure 22: Diabetes Care Devices, Spain, Company Share (%), 2008 43
Figure 23: Glucose Monitoring, Spain, Revenue ($ mn) by Segment, Historic, 2000-2008 44
Figure 24: Glucose Monitoring, Spain, Revenue ($ mn) by Segment, Forecast, 2008-2015 45
Figure 25: Blood Glucose Meters, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 46
Figure 26: Blood Glucose Meters, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 47
Figure 27: Glucose Monitoring, Spain, Volume (Units) by Segment, Historic, 2000-2008 48
Figure 28: Glucose Monitoring, Spain, Volume (Units) by Segment, Forecast, 2008-2015 49
Figure 29: Glucose Monitoring, Spain, Company Share (%), 2008 53
Figure 30: Insulin Delivery, Spain, Revenue ($ mn) by Segment, Historic, 2000-2008 54
Figure 31: Insulin Delivery, Spain, Revenue ($ mn) by Segment, Forecast, 2008-2015 55
Figure 32: Insulin Pens, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 56
Figure 33: Insulin Pens, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 57
Figure 34: Insulin Pens, Spain, Volume (Units) by Sub-Segment, Historic, 2000-2008 59
Figure 35: Insulin Pens, Spain, Volume (Units) by Sub-Segment, Forecast, 2008-2015 60
Figure 36: Insulin Delivery, Spain, Company Share (%), 2008 63
Figure 37: F. Hoffmann-La Roche Ltd Value Chain Analysis 65
Figure 38: Bayer HealthCare AG Value Chain Analysis 69
Figure 39: Abbott Laboratories Value Chain Analysis 73
Figure 40: Becton, Dickinson and Company Value Chain Analysis 77
Figure 41: Medtronic, Inc. Value Chain Analysis 82
Figure 42: Eli Lilly and Company Value Chain Analysis 92
Figure 43: Terumo Corporation Value Chain Analysis 100
Figure 44: Smiths Medical Value Chain Analysis 105
Figure 45: Global Markets Direct Methodology 107

Visitor Comments

All Comments

Change Currency

GBP

EURO

USD

Last Viewed

Spain Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Southern Africa Telecommunications Report Q1 2010

South Korea Information Technology Report Q3 2010

South Korea Agribusiness Q2 2010

South and Central America Paint Additives Market Analysis and Forecasts to 2020

Healthcare and Medical Company Profiles

Healthcare and Medical Company Profiles contain up to date financial, strategic, operational, SWOT analysis and product information on the activities of thousands of healthcare and medical companies.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Healthcare and Medical	Type	Keywords Phrase All Words Any Word
Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.	Country	Industry Sector
Publisher	Order By Relevance Date	Published In

Spain Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Select License Type

Speak to an Advisor

Select License Type

Table of Contents

Visitor Comments

Change Currency

Last Viewed

Healthcare and Medical Company Profiles

Become an Affiliate

Custom Research

News

Market Insights

Companies And Markets

Customer Support

Corporate Accounts

Contact Details

Contrast settings

Text size settings

All
Afghanistan
Africa
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Asia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Bouvet Island
Brazil
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean
Cayman Islands
Central African Republic
Central America
Central Europe
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Conch Republic
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of Congo
Denmark
Djibouti
Dominica
Dominican Republic
Eastern Europe
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Europe
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Global
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guernsey
Guinea
Guinea Bissau
Guyana
Haiti
Heard Island and McDonald Islans
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Ivory Coast (Cote D`Ivoire)
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kurdistan
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Middle East
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North America
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Scandinavia
Schengen countries
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South America
South Georgia and the South Sandwich Islands
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste (East Timor)
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe

All
Aerospace
Agriculture, Farming & Raw Materials
Automotive and Parts
Business Services
Chemicals
Construction
Consumer Goods
Defence
Energy and Utilities
Environmental
Finance and Banking
Food and Drink
Healthcare and Medical
Industrial
Information Technology
Leisure
Logistics
Media
Paper and Packaging
Publishing and Printing
Real Estate
Retail
Security
Telecommunications
Textiles and Clothing
Transportation
Travel